51 results
D
KA
Kineta, Inc.
20 Oct 23
$2.89 mm in options / securities to be acquired, 1 investor
1:04pm
Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
D
KA
Kineta, Inc.
29 Dec 22
$30.00 mm in equity, sold $7.50 mm, 17 investors
3:12pm
Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians …
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
8-K
EX-99.5
KA
Kineta, Inc.
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
amounts paid to health care providers, including the Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System, which may result … of health care and the pricing and reimbursement of products in that context. In general, however, the healthcare budgetary constraints in most EU
8-K
EX-99.6
nq08owcp6mci8c
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
dn7nq5 eaku
10 Nov 22
Prospectus supplement
4:21pm
425
xrovrpgkt0
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.1
04kyqcsd
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-10.1
2zpvh
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am